Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging Ib/II trial of Sabin strain inactivated poliovirus vaccine (Vero cell) in different age groups
CTR20181477Phase 2Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Aug 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Beijing Minhai Biological. Started Aug 2018; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20181477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181477.